Caricamento...
Chimeric antigen receptor T-cell therapy in AML: How close are we?
The majority of patients presenting with acute myeloid leukemia (AML) initially respond to chemotherapy but post-remission therapy is required to consolidate this response and achieve long-term disease-free survival. The most effective form of post-remission therapy relies on T-cell immunotherapy in...
Salvato in:
| Pubblicato in: | Best Pract Res Clin Haematol |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5131522/ https://ncbi.nlm.nih.gov/pubmed/27890255 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.beha.2016.10.004 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|